24 min
Breast Cancer Specialist Dr. Mark Moasser Discusses Overcoming Barriers to Clinical Trial Access Precision Medicine Podcast
-
- Medicine
Dr. Mark Moasser (https://www.trapelohealth.com/breast-cancer-clinical-trials), a physician-scientist and breast cancer specialist at the University of California, San Francisco discusses his research focus on the HER2 oncogene, the latest trial findings and the importance of improving patient access to clinical trials.
At Trapelo, connecting oncologists with patient-appropriate clinical trials (https://www.trapelohealth.com/for-oncologists) is a major part of our mission, so we were grateful for the opportunity to talk to Dr. Moasser and learn more about his thoughts on this matter. Tune in to the full episode to learn more about his current research and perspective on the future of precision medicine.
Dr. Mark Moasser (https://www.trapelohealth.com/breast-cancer-clinical-trials), a physician-scientist and breast cancer specialist at the University of California, San Francisco discusses his research focus on the HER2 oncogene, the latest trial findings and the importance of improving patient access to clinical trials.
At Trapelo, connecting oncologists with patient-appropriate clinical trials (https://www.trapelohealth.com/for-oncologists) is a major part of our mission, so we were grateful for the opportunity to talk to Dr. Moasser and learn more about his thoughts on this matter. Tune in to the full episode to learn more about his current research and perspective on the future of precision medicine.
24 min